Tapewire

Nasdaq · USD

TMCI

TREACE MEDICAL CONCEPTS, INC.

Export transactions ↓
Tapewire entity
5943
SEC CIK
0001630627
Parsed reports
290

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202650
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 27, 2021 Filed Apr 29, 2021 21:13 UTC OtherSeries A Preferred Stock · Derivative 9,906 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017470 · doc4.xml · derivative · entry 5

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 9,906

Underlying: Common Stock · 9,906 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F4 · derivative.exercise_price: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F4 · derivative.exercise_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F4 · derivative.expiration_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:13 UTC SaleCommon Stock 401,250 $17.00 $6,821,250.00
Disclosure

SEC source: 0000899243-21-017470 · doc4.xml · nonDerivative · entry 2

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 2,306,606

F2 · kind: These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.

F2 · price: These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:13 UTC ConversionCommon Stock 427,875 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-017470 · doc4.xml · nonDerivative · entry 1

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 2,707,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:17 UTC ConversionSeries A Preferred Stock · Derivative 299,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017480 · doc4.xml · derivative · entry 3

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 0

Underlying: Common Stock · 299,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:17 UTC OtherSeries A Preferred Stock · Derivative 6,931 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017480 · doc4.xml · derivative · entry 2

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 299,509

Underlying: Common Stock · 6,931 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

F2 · derivative.exercise_price: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

F2 · derivative.exercise_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

F2 · derivative.expiration_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:17 UTC ConversionCommon Stock 299,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-017480 · doc4.xml · nonDerivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 2,820,240

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:16 UTC ConversionSeries A Preferred Stock · Derivative 699,141 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017476 · doc4.xml · derivative · entry 6

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 699,141 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:16 UTC OtherSeries A Preferred Stock · Derivative 16,180 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017476 · doc4.xml · derivative · entry 5

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 699,141

Underlying: Common Stock · 16,180 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_price: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.expiration_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:16 UTC ConversionCommon Stock 699,141 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-017476 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,697,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
April 27, 2021 Filed Apr 30, 2021 01:24 UTC
Ferguson Joe W.SVP, Research & Development
ConversionSeries A Preferred Stock · Derivative 85,575 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017495 · doc4.xml · derivative · entry 4

Ferguson Joe W. · CIK 0001856496 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Indirect · Pensco Trust Company FBO Joe William Ferguson

Disclosed balance after: 0

Underlying: Common Stock · 85,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
April 27, 2021 Filed Apr 30, 2021 01:24 UTC
Ferguson Joe W.SVP, Research & Development
OtherSeries A Preferred Stock · Derivative 1,981 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-017495 · doc4.xml · derivative · entry 3

Ferguson Joe W. · CIK 0001856496 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Indirect · Pensco Trust Company FBO Joe William Ferguson

Disclosed balance after: 85,575

Underlying: Common Stock · 1,981 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_price: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.expiration_date: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

Read SEC document
April 27, 2021 Filed Apr 30, 2021 01:24 UTC
Ferguson Joe W.SVP, Research & Development
ConversionCommon Stock 85,575 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-017495 · doc4.xml · nonDerivative · entry 1

Ferguson Joe W. · CIK 0001856496 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Indirect · Pensco Trust Company FBO Joe William Ferguson

Disclosed balance after: 85,575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 00:59 UTC
Scanlan Sean F.See Remarks
GrantStock Option (Right to Buy) · Derivative 66,875 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017032 · doc4.xml · derivative · entry 1

Scanlan Sean F. · CIK 0001856371 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,875

Underlying: Common Stock · 66,875 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 26, 2021 20:57 UTC
Frias Jaime A.See Remarks
GrantStock Option (Right to Buy) · Derivative 93,625 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017028 · doc4.xml · derivative · entry 1

Frias Jaime A. · CIK 0001856367 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,625

Underlying: Common Stock · 93,625 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 26, 2021 20:56 UTC
Owens Daniel E.Chief HR Officer
GrantStock Option (Right to Buy) · Derivative 73,563 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017025 · doc4.xml · derivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,563

Underlying: Common Stock · 73,563 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 26, 2021 20:55 UTC
Rajhansa DipakSVP, Sales
GrantStock Option (Right to Buy) · Derivative 13,375 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017021 · doc4.xml · derivative · entry 1

Rajhansa Dipak · CIK 0001856376 · SVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,375

Underlying: Common Stock · 13,375 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 01:15 UTC
Hair MarkChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 93,625 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017038 · doc4.xml · derivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,625

Underlying: Common Stock · 93,625 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 00:55 UTC GrantStock Option Right to Buy · Derivative 21,240 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017024 · doc4.xml · derivative · entry 1

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,240

Underlying: Common Stock · 21,240 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 26, 2021 21:06 UTC GrantStock Option Right to Buy · Derivative 21,240 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017036 · doc4.xml · derivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,240

Underlying: Common Stock · 21,240 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 26, 2021 21:01 UTC GrantStock Option Right to Buy · Derivative 21,240 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017034 · doc4.xml · derivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,240

Underlying: Common Stock · 21,240 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 00:59 UTC GrantStock Option Right to Buy · Derivative 21,240 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017033 · doc4.xml · derivative · entry 1

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,240

Underlying: Common Stock · 21,240 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
April 22, 2021 Filed Apr 27, 2021 00:55 UTC
Ferguson Joe W.SVP, Research & Development
GrantStock Option (Right to Buy) · Derivative 33,438 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0000899243-21-017023 · doc4.xml · derivative · entry 1

Ferguson Joe W. · CIK 0001856496 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,438

Underlying: Common Stock · 33,438 shares

Expires 2031-04-22

F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.